UPPSALA, Sweden — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the collaboration with Eurofins Genomics to bolster its offerings in the fields of research, population health, and regulated clinical trials through the application of Olink technology. The Olink platform represents the cutting edge in proteomics technology, delivering exceptional sensitivity and specificity for protein biomarker […]
Caption: (Left) Pyrophosphatase (inorganic), HQ; (Right) T7 RNA Polymerase, HQ. Saint-Germain-en-Laye, France – Takara Bio Europe (TBE) announced today the launch of new High Quality (HQ) grade mRNA production enzymes “T7 RNA polymerase, HQ” and “Pyrophosphatase (inorganic), HQ” suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing. HQ grade enzymes have features […]
AMSBIO has supplied a custom monoclonal antibody (mAB) to researchers at the TU Dortmund** in Germany to unravel the role of EDI3 in breast cancer development, its regulation by HER2 signalling, and its potential as a therapeutic target. Characterized by the overexpression of the Human Epidermal growth factor Receptor 2 (HER2) – HER2+ breast cancer is a highly aggressive disease […]
FARMINGDALE, NY — Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors and departing the Company effective September 5, 2023, with Enzo’s Chief Operating Officer, Kara Cannon, assuming the role of interim CEO. “We thank Hamid for the commitment he […]
Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseases BOULDER, Colo. — SomaLogic, Inc., a leader in proteomics technology, announced today that it is extending its collaborative agreement with global healthcare innovator, Novo Nordisk. As part of the agreement, which now extends into the end of […]
Together, the companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics Caption: GenNext & SCIEX Co-Market High Order Structure Analysis (HOS) Workflow Half Moon Bay, CA – GenNext Technologies, Inc., provider of novel instrumentation, software, and services for structural biology […]
The new AutoFox™ System promises to deliver hands-free, high-throughput Hydroxyl Radical Protein Footprinting for sophisticated Higher Order Structural (HOS) analysis Caption: GenNext Unveils the First Fully Automated HRPF System. Half Moon Bay, CA – GenNext Technologies, Inc., provider of novel instrumentation, software, and services for structural biology announced the release of the AutoFox Protein Footprinting […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a drug discovery agreement with Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) to discover and develop novel antibodies for the treatment of autoimmune diseases. […]
WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Abcam plc (NASDAQ: ABCM), a leading global supplier of protein consumables, pursuant to which Danaher will acquire all of the outstanding shares of Abcam for $24.00 per share in cash, […]
San Jose, CA (USA) & Hamburg (Germany) — Takara Bio Inc. (Takara Bio) and Eppendorf SE, two renowned leaders in the life science industry, are pleased to announce their collaboration through a strategic co-marketing agreement. This partnership aims at jointly developing cutting-edge solutions to automate Takara Bio’s chemistries on Eppendorf epMotion® automation platforms. “The integration […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
